Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

D&K Healthcare Q3 Revenue Increases 42% And EPS Rise 40%; Posts All-time Quarterly Revenue, EBITDA, Net Income And EPS Records.


Business Editors

ST. LOUIS--(BUSINESS WIRE)--April 24, 2002

Raises FY 2002 Net Sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 Guidance to $2.4 Billion and

EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  Guidance to $1.39 (Adjusted for 2-For-1 Stock Split)

D&K Healthcare Resources, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: DKWD DKWD Disk Write Data ) today reported all-time all-time
adj.
Exceeding all others up to the present time: an all-time speed skating record.


all-time
Adjective

Informal
 record quarterly net sales, earnings before interest, taxes, depreciation and amortization Earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP metric that can be used to evaluate a company's profitability.
:EBITDA = Operating Revenue – Operating Expenses + Other Revenue
 (EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become ), net income and diluted earnings per share diluted earnings per share

An earnings measure calculated by dividing net income less preferred stock dividends for a period by the average number of shares of common stock that would be outstanding if all convertible securities were converted into shares of
 for its fiscal third quarter ended March 31, 2002.


                       Summary Financial Results
   (in millions, except per share data, and adjusted for the 2-for-1
                 stock split effective April 12, 2002)
----------------------------------------------------------------------
                Q3`02    Q3`01   Change    YTD `02   YTD `01    Change
----------------------------------------------------------------------
Net Sales       $695.2  $490.5    + 42%   $1,816.0   $1,196.6    + 52%
EBITDA          $ 16.7   $ 9.7    + 73%     $ 37.5     $ 22.2    + 69%
Net Income      $  7.3   $ 3.2   + 128%     $ 15.5      $ 6.5   + 138%
Diluted EPS     $ 0.49   $0.35    + 40%     $ 1.05     $ 0.73    + 44%
Diluted Shares    14.8     9.2    + 61%       14.7        9.0    + 62%


J. Hord Armstrong, III, Chairman and Chief Executive Officer, commented, "D&K surpassed every performance goal we set for the quarter and year to date, establishing a number of all-time records. Given the benefits of our expanded capital base, our strong operating performance and the positive long-term Long-term

Three or more years. In the context of accounting, more than 1 year.


long-term

1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term.
 trends in pharmaceutical demand, we are increasing our guidance for FY 2002 net sales to $2.4 billion and raising our FY 2002 EPS guidance to $1.39, reflecting the impact of the recently completed 2-for-1 stock split. Our previous FY 2002 guidance was $2.3 billion in net sales with EPS of $1.33, adjusted for the split."

Martin D. Wilson Wilson, city (1990 pop. 36,930), seat of Wilson co., E N.C., in a rich agricultural region; inc. 1849. It is a commercial and industrial center with a large tobacco market. Manufactures include textile goods (especially clothing), metal products, and processed foods. , President and Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
, added, "D&K generated sales of $277.3 million in the independent and regional pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent.  trade class in the third quarter, an increase of $87.9 million, or 46.4%, over the third quarter of last year, reflecting our high level of personalized per·son·al·ize  
tr.v. per·son·al·ized, per·son·al·iz·ing, per·son·al·iz·es
1. To take (a general remark or characterization) in a personal manner.

2. To attribute human or personal qualities to; personify.
 service. Revenue from the Diversified diversified (di·verˑ·s  Healthcare acquisition in June June: see month.  2001 represented 51.2% of the increase, with the remaining 48.8% coming from same store sales Same Store Sales

A statistic used in retail industry analysis. It compares sales of stores that have been open for a year or more.

Notes:
This statistic allows investors to determine what portion of new sales has come from sales growth and what portion from the opening of
 growth and new customer wins.

"D&K's national pharmacy chain business achieved sales of $385.8 million in the third quarter, an increase of 41.0%, or $112.1 million. The improvement in this trade class over the same period last year is largely due to strong relationships with both suppliers and the chains, which we have been able to optimize optimize - optimisation  with our improved capital structure. It is worth noting that our inventories at March 31, 2002 were $430 million, as we took advantage of attractive purchasing opportunities and positioned D&K to support its sales growth."

Mr. Wilson continued, "Consolidated gross margin for the quarter totaled 4.36%, compared to 4.19% last year. Illustrating the significant operating leverage Operating Leverage

A measurement of the degree to which a firm or project relies on fixed rather than variable costs.

Notes:
The higher the degree of operating leverage, the greater the potential danger from forecasting risk.
 in our business model, our operating margin Operating Margin

A ratio used to measure a company's pricing strategy and operating efficiency.

Calculated by:
 for the quarter increased over 25% to 2.25%, up from 1.80% in the third quarter of fiscal 2001."

Thomas (language) Thomas - A language compatible with the language Dylan(TM). Thomas is NOT Dylan(TM).

The first public release of a translator to Scheme by Matt Birkholz, Jim Miller, and Ron Weiss, written at Digital Equipment Corporation's Cambridge Research Laboratory runs
 S. Hilton Hil·ton   , Conrad Nicholson 1887-1979.

American hotel-chain organizer who acquired hotels in many American cities and in 1946 founded the Hilton Hotel Corporation.
, Senior Vice President and Chief Financial Officer, added, "The combination of enhanced capital resources, excellent execution, operational efficiencies and favorable fa·vor·a·ble  
adj.
1. Advantageous; helpful: favorable winds.

2. Encouraging; propitious: a favorable diagnosis.

3.
 interest rates contributed to this record setting quarter. Looking forward, we are expecting the gross margin for fiscal 2002 to be approximately 4.2%. Operating margin for fiscal 2002 should slightly exceed 1.8%. Total weighted average borrowings increased $62 million over third quarter last year to $248 million during the quarter, but were offset by a 320 basis point decline in weighted average interest rates compared to the same period last year, substantially accounting for the 14.4% decrease in net interest expense."

About D&K Healthcare Resources

With trailing twelve month revenues of $2.27 billion, St. Louis-based D&K Healthcare Resources, Inc., is a wholesale distributor of pharmaceutical and related healthcare and beauty aid products to independent and regional pharmacies This article is a list of major pharmacies (also known as chemists and drugstores) by country. Australia
Pharmacies in Australia are mostly independently-owned by pharmacists, often operated as franchises of retail brands offered by the three major
, national pharmacy chains and other healthcare providers. D&K currently services customers in 24 states primarily in the Midwest and South from distribution facilities in Cape Girardeau Cape Girardeau (jĭrär`dō, jērərdō`), city (1990 pop. 61,633), Cape Girardeau co., SE Mo., overlooking the Mississippi River; founded 1793, inc. as a city 1843. , MO; Weston, FL; Lexington, KY; Minneapolis, MN; Aberdeen, SD; and Owensboro, KY. D&K also offers a variety of additional services to its customers, including inventory management, services designed to contain costs, information technology systems and various marketing programs related to generic pharmaceuticals and other products. In addition, D&K owns a 70% equity interest in Pharmaceutical Buyers, Inc., a recognized alternate-site group purchasing organization A group purchasing organization is an entity that leverages the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO members. Many GPOs are funded by administrative fees that are actually paid by the vendors. . D&K invites you to visit its Web site at http://www.dkwd.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Provisions

This press release may contain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward-looking statements are inherently subject to risks and uncertainties. D&K's actual results could differ materially from those currently anticipated due to a number of factors, including without limitation, the competitive nature of the wholesale pharmaceutical distribution industry, with many competitors having substantially greater resources than D&K, and D&K's customers and suppliers generally having the right to terminate or reduce their purchases or shipments on relatively short notice, the changing business and regulatory environment of the healthcare industry in which D&K operates, changes in interest rates and other factors set forth in reports and other documents filed by D&K with the Securities and Exchange Commission from time to time. D&K undertakes no obligation to publicly update or revise any forward-looking statements.


                    D&K HEALTHCARE RESOURCES, INC.
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                 (In thousands, except per share data)

                                    Three Months Ended
                                       (Unaudited)
                ------------------------------------------------------
                 Mar. 31,     % of      Mar. 31,     % of         %
                   2002    Net Sales     2001      Net Sales    Change
                ------------------------------------------------------

Net sales       $ 695,241   100.00%   $  490,469     100.00%     41.8%
Cost of sales     664,894    95.64%      469,896      95.81%     41.5%
                ---------             ----------
  Gross profit     30,347     4.36%       20,573       4.19%     47.5%

Operating
 expenses          14,672     2.11%       11,740       2.39%     25.0%
                ---------             ----------
 Income from
  operations       15,675     2.25%        8,833       1.80%     77.5%

Other income
 (expense):
   Interest
    expense, net   (2,847)   -0.41%       (3,325)     -0.68%    -14.4%
  Other, net        (756)    -0.11%         (262)     -0.05%    188.5%
                ---------             -----------

Pretax earnings    12,072     1.74%        5,246       1.07%    130.1%
Income tax
 provision          4,770     0.69%        2,046       0.42%    133.1%
                ---------             ----------
Net income        $ 7,302     1.05%     $  3,200       0.65%    128.2%
                =========             ==========

EBITDA           $ 16,747     2.41%     $  9,670       1.97%     73.2%

Basic earnings
 per share(a)     $  0.51               $   0.38                 34.2%
Diluted earnings
  per share(a)    $  0.49               $   0.35                 40.0%

Basic common shares
  outstanding(a)   14,366                  8,477                 69.5%
Diluted common shares
  outstanding(a)   14,775                  9,192                 60.7%

(a) Shares and related EPS have been adjusted to reflect the 2 for 1
stock split effective April 12, 2002.


                    D&K HEALTHCARE RESOURCES, INC.
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                 (In thousands, except per share data)

                                     Nine Months Ended
                                        (Unaudited)
                ------------------------------------------------------
                 Mar. 31,      % of      Mar. 31,    % of         %
                   2002     Net Sales      2001    Net Sales   Change
                ------------------------------------------------------

Net sales      $1,816,030   100.00%    $1,196,646    100.00%     51.8%
Cost of sales   1,739,330    95.78%     1,146,057     95.77%     51.8%
               ----------              ----------
 Gross profit      76,700     4.22%        50,589      4.23%     51.6%

Operating
 expenses          42,441     2.34%        30,895      2.58%     37.4%
               ----------              ----------
 Income from
   operations      34,259     1.89%        19,694      1.65%     74.0%

Other income
 (expense):
 Interest expense,
  net              (7,239)   -0.40%        (9,011)    -0.75%    -19.7%
  Other, net       (1,349)   -0.07%             4      0.00%      N/M
               ----------               ----------
Pretax earnings    25,671     1.41%        10,687      0.89%    140.2%
Income tax
 provision         10,140     0.56%         4,168      0.35%    143.3%
               ----------               ----------
Net income       $ 15,531     0.86%      $  6,519      0.54%    138.2%
               ==========               ==========              ======

EBITDA          $  37,504     2.07%      $ 22,203      1.86%     68.9%

Basic earnings
 per share(a)    $   1.09                $   0.77                41.6%
Diluted earnings
 per share(a)    $   1.05                $   0.73                43.8%


Basic common shares
 outstanding(a)    14,199                   8,432                68.4%
Diluted common shares
 outstanding(a)    14,655                   9,032                62.3%

(a) Shares and related EPS have been adjusted to reflect the 2 for 1
stock split effective April 12, 2002.


                    D&K HEALTHCARE RESOURCES, INC.
                 CONDENSED CONSOLIDATED BALANCE SHEETS
                            (in thousands)

                                       Mar. 31,              June 30,
                                        2002                   2001
                                  ----------------       -------------
                                     (Unaudited)
     Assets

     Cash                               $  9,490            $   7,516
     Accounts receivable                  35,254               45,131
     Inventories                         430,046              214,739
     Other current assets                  2,694                2,664
                                     -----------         -------------
        Total current assets             477,484              270,050
     Property and equipment, net          10,897                9,703
     Investment in PBI                         -                4,552
     Other assets                         59,000               45,899
                                     -----------         -------------
        Total assets                   $ 547,381           $  330,204
                                     ===========         =============

  Liabilities and Stockholders' Equity

     Accounts payable                  $ 239,849            $ 158,930
     Current portion long-term debt        1,159                  320
     Other current liabilities            14,227               13,267
                                     ------------     ----------------
        Total current liabilities        255,235              172,517
     Long-term liabilities                 2,622                2,300
     Long-term debt                      126,924               94,489
     Deferred income taxes                 2,925                3,388
     Stockholders' equity                159,675               57,510
                                     ------------       --------------
     Total liabilities and
      stockholders' equity             $ 547,381            $ 330,204
                                     ============       ==============


Conference Call/Web Cast: Today, Wednesday, April 24

at 10:30 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
 

Webcast and replay: www.dkwd.com/irevents.htm.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 24, 2002
Words:1527
Previous Article:Jupiter Partners Sells Ownership Interest in Core-Mark International to Fleming Companies in $390 Million Transaction.
Next Article:Core-Mark International Significantly Expands Distribution Capabilities Through Sale to Fleming.
Topics:



Related Articles
D&K Healthcare Resources Reports Record Q2 Sales of $355 Million, EBITDA Of $6.3 Million and EPS Of $0.40.
D&K Healthcare Resources Reports Record Q3 Net Sales, EBITDA and Earnings Per Share.
D&K Healthcare Resources Reports Record Q4 EPS of $0.56 and FY 2001 EPS of $2.02; Initiates FY 2002 Revenue and Earnings Guidance.
D&K Healthcare Resources Achieves Record Quarterly Net Sales of $529 Million and Record Q1 EPS of $0.50; D&K Raises FY 2002 EPS Guidance to $2.60...
Continental Home Healthcare Announces Nine Month Results; Revenues Increased 47%, EBITDA up 78%.
D&K Healthcare Resources Achieves All-Time Record Quarterly Net Sales of $592 Million and Record Q2 EPS Of $0.62.
D&K Healthcare FY 2002 EPS Rise 41% to a Record $1.42 On a Record $2.45 Billion in Net Sales, a 49% Increase.
D&K Healthcare Resources Reports Q3 Fiscal 2003 Results and Provides Q4 Earnings Guidance.
FindWhat.Com Announces Record Third Quarter Results.
Chattem Announces Record Fourth Quarter and Fiscal 2004 Sales and Earnings Per Share; Gives Outlook for Fiscal 2005.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles